Working together for personalized medicine in South East Asians

About Seapharm

Pharmacogenomics is the study of population genetic variability that affects the use of drugs. In a hypothesis situation, a particular drug might be excellence for most people, but it might not...

Read more

Personalized medicine for South East Asian populations

Pharmacogenomics is involving prevention of rare/uncommon life-threatening side effects, and this is the utmost important scheme in practice of medicine "First, do no harm". To enable the research and development of pharmacogenomics of rare/uncommon side effects, consortium is the approach to gather researchers with same research interests and equipped them necessarily resources for tackle the problems together.